Key Metrics

CiteScore

6.2

Eigenfactor

0.005 - 0.01

H-Index

Impact Factor

< 5

SJR

Q1Oncology

SNIP

0.85

Recommended pre-submission checks

Topics Covered on Investigational New Drugs

Investigational New Drugs Journal Specifications

Overview
Publisher	SPRINGER
Language	English
Frequency	Bi-monthly
General Details
Language	English
Frequency	Bi-monthly
Publication Start Year	1983
Publisher URL	Visit website
Website URL	Visit website

View less

Planning to publish in Investigational New Drugs ?

Upload your Manuscript to get

Degree of match
Common matching concepts
Additional journal recommendations

Check your researchless than 30 sec

Recently Published Papers in Investigational New Drugs

Evaluating pegenzileukin (SAR444245/THOR-707) in combination with pembrolizumab or cetuximab in advanced metastatic gastrointestinal cancer: the PEGATHOR phase 2 study.

22 Jun 2026
Investigational new drugs

Characterizing the post-market safety profile of cemiplimab: a pharmacovigilance study of the FDA adverse events reporting system database.

19 Jun 2026
Investigational new drugs

Clinical features, diagnosis and prognosis of nivolumab-associated fulminant type 1 diabetes.

17 Jun 2026
Investigational new drugs

Effector-to-target ratio as a translational bottleneck for CD33 T-cell engagers in acute myeloid leukemia: a quantitative reanalysis of AMG330.

10 Jun 2026
Investigational new drugs

Retraction Note: The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells.

30 May 2026
Investigational new drugs

Preclinical evaluation and mechanistic analysis of antitumor effects of the novel anti-CD147 antibody DS-1471a in liver cancer models.

29 May 2026
Investigational new drugs

Evaluating pegenzileukin (SAR444245/THOR-707) in combination with pembrolizumab or cetuximab in advanced metastatic gastrointestinal cancer: the PEGATHOR phase 2 study.

22 Jun 2026
Investigational new drugs

Characterizing the post-market safety profile of cemiplimab: a pharmacovigilance study of the FDA adverse events reporting system database.

19 Jun 2026
Investigational new drugs

Clinical features, diagnosis and prognosis of nivolumab-associated fulminant type 1 diabetes.

17 Jun 2026
Investigational new drugs

Effector-to-target ratio as a translational bottleneck for CD33 T-cell engagers in acute myeloid leukemia: a quantitative reanalysis of AMG330.

10 Jun 2026
Investigational new drugs

Retraction Note: The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells.

30 May 2026
Investigational new drugs

Preclinical evaluation and mechanistic analysis of antitumor effects of the novel anti-CD147 antibody DS-1471a in liver cancer models.

29 May 2026
Investigational new drugs

View all papers for this journal

FAQs on Investigational New Drugs

How long has Investigational New Drugs been actively publishing?

What is the publishing frequency of Investigational New Drugs?

How many articles did Investigational New Drugs publish last year?

What is the eISSN & pISSN for Investigational New Drugs?

What is Citescore for Investigational New Drugs?

What is the H Index for Investigational New Drugs ?

What is SNIP score for Investigational New Drugs?

What is the SJR for Investigational New Drugs?

Who is the publisher of Investigational New Drugs?

Global Journal Library:

Q: How long has Investigational New Drugs been actively publishing?

Investigational New Drugs has been in operation since 1983 till date.

Q: What is the publishing frequency of Investigational New Drugs?

Investigational New Drugs published with a Bi-monthly frequency.

Q: How many articles did Investigational New Drugs publish last year?

In 2025, Investigational New Drugs publsihed 101 articles.

Q: What is the eISSN & pISSN for Investigational New Drugs?

For Investigational New Drugs, eISSN is 1573-0646 and pISSN is 0167-6997.

Q: What is Citescore for Investigational New Drugs?

Citescore for Investigational New Drugs is 6.2.

Q: What is the H Index for Investigational New Drugs ?

H Index for Investigational New Drugs is 94.

Q: What is SNIP score for Investigational New Drugs?

SNIP score for Investigational New Drugs is 0.85.

Q: What is the SJR for Investigational New Drugs?

SJR for Investigational New Drugs is Q1.

Q: Who is the publisher of Investigational New Drugs?

SPRINGER is the publisher of Investigational New Drugs.

Investigational New Drugs : Impact Factor & More